{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:38:56Z","timestamp":1792543136742,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170547 ; 81873558"],"award-info":[{"award-number":["82170547 ; 81873558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12920-6","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:25:09Z","timestamp":1792495509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting pyroptosis in intestinal and systemic inflammatory diseases: mechanisms and therapeutic opportunities"],"prefix":"10.1007","volume":"53","author":[{"given":"Jiamin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"12920_CR1","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathmechdis-051222-115023","volume":"20","author":"A Moyer","year":"2025","unstructured":"Moyer A, Tanaka K, Cheng EH (2025) Apoptosis in Cancer Biology and Therapy. Annu Rev Pathol 20:303\u2013328. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-051222-115023","journal-title":"Annu Rev Pathol"},{"key":"12920_CR2","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS (2021) Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol 18:1106\u20131121. https:\/\/doi.org\/10.1038\/s41423-020-00630-3","journal-title":"Cell Mol Immunol"},{"key":"12920_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA (2024) The cell biology of ferroptosis. Nat Rev Mol Cell Biol 25:424\u2013442. https:\/\/doi.org\/10.1038\/s41580-024-00703-5","journal-title":"Nat Rev Mol Cell Biol"},{"key":"12920_CR4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41422-025-01107-6","volume":"35","author":"P Broz","year":"2025","unstructured":"Broz P (2025) Pyroptosis: molecular mechanisms and roles in disease. Cell Res 35:334\u2013344. https:\/\/doi.org\/10.1038\/s41422-025-01107-6","journal-title":"Cell Res"},{"key":"12920_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X (2021) Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther 6:128. https:\/\/doi.org\/10.1038\/s41392-021-00507-5","journal-title":"Signal Transduct Target Ther"},{"key":"12920_CR6","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1038\/540S97a","volume":"540","author":"R Hodson","year":"2016","unstructured":"Hodson R (2016) Inflammatory bowel disease. Nature 540:S97. https:\/\/doi.org\/10.1038\/540S97a","journal-title":"Nature"},{"key":"12920_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","volume":"5","author":"S Alatab","year":"2020","unstructured":"Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, Safiri S, Sadeghi A, Nixon MR, Abdoli A, Abolhassani H, Alipour V, Almadi MAH, Almasi-Hashiani A, Anushiravani A, Arabloo J, Atique S, Awasthi A, Badawi A, Baig AAA, Bhala N, Bijani A, Biondi A, Borz\u00ec AM, Burke KE, Carvalho F, Daryani A, Dubey M, Eftekhari A, Fernandes E, Fernandes JC, Fischer F, Haj-Mirzaian A, Haj-Mirzaian A, Hasanzadeh A, Hashemian M, Hay SI, Hoang CL, Househ M, Ilesanmi OS, Balalami NJ, James SL, Kengne AP, Malekzadeh MM, Merat S, Meretoja TJ, Mestrovic T, Mirrakhimov EM, Mirzaei H, Mohammad KA, Mokdad AH, Monasta L, Negoi I, Nguyen TH, Nguyen CT, Pourshams A, Poustchi H, Rabiee M, Rabiee N, Ramezanzadeh K, Rawaf DL, Rawaf S, Rezaei N, Robinson SR, Ronfani L, Saxena S, Sepehrimanesh M, Shaikh MA, Sharafi Z, Sharif M, Siabani S, Sima AR, Singh JA, Soheili A, Sotoudehmanesh R, Suleria HAR, Tesfay BE, Tran B, Tsoi D, Vacante M, Wondmieneh AB, Zarghi A, Zhang ZJ, Dirac M, Malekzadeh R, Naghavi M (2020) The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 5:17\u201330. https:\/\/doi.org\/10.1016\/S2468-1253(19)30333-4","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"12920_CR8","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, Sung JJY, Kaplan GG (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet Lond Engl 390:2769\u20132778. https:\/\/doi.org\/10.1016\/S0140-6736(17)32448-0","journal-title":"Lancet Lond Engl"},{"key":"12920_CR9","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1016\/j.cgh.2023.08.013","volume":"21","author":"L Xu","year":"2023","unstructured":"Xu L, He B, Sun Y, Li J, Shen P, Hu L, Liu G, Wang J, Duan L, Zhan S, Wang S (2023) Incidence of Inflammatory Bowel Disease in Urban China: A Nationwide Population-based Study. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 21:3379\u20133386e29. https:\/\/doi.org\/10.1016\/j.cgh.2023.08.013","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"12920_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","volume":"23","author":"L Vande Walle","year":"2024","unstructured":"Vande Walle L, Lamkanfi M (2024) Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nat Rev Drug Discov 23:43\u201366. https:\/\/doi.org\/10.1038\/s41573-023-00822-2","journal-title":"Nat Rev Drug Discov"},{"key":"12920_CR11","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41423-023-01107-9","volume":"20","author":"S Oh","year":"2023","unstructured":"Oh S, Lee J, Oh J, Yu G, Ryu H, Kim D, Lee S (2023) Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation and assembly drive PANoptosis. Cell Mol Immunol 20:1513\u20131526. https:\/\/doi.org\/10.1038\/s41423-023-01107-9","journal-title":"Cell Mol Immunol"},{"key":"12920_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu J, Wu H (2023) Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation. Annu Rev Immunol 41:301\u2013316. https:\/\/doi.org\/10.1146\/annurev-immunol-081022-021207","journal-title":"Annu Rev Immunol"},{"key":"12920_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.immuni.2018.04.032","volume":"49","author":"A Di","year":"2018","unstructured":"Di A, Xiong S, Ye Z, Malireddi RKS, Kometani S, Zhong M, Mittal M, Hong Z, Kanneganti TD, Rehman J, Malik AB (2018) The TWIK2 potassium efflux channel in macrophages mediates NLRP3 inflammasome-induced inflammation. Immunity 49:56\u201365e4. https:\/\/doi.org\/10.1016\/j.immuni.2018.04.032","journal-title":"Immunity"},{"key":"12920_CR14","doi-asserted-by":"publisher","first-page":"108803","DOI":"10.1016\/j.pharmthera.2025.108803","volume":"267","author":"W Zhang","year":"2025","unstructured":"Zhang W, Zhang L, Fu S, Yan R, Zhang X, Song J, Lu Y (2025) Roles of NLRC4 inflammasome in neurological disorders: Mechanisms, implications, and therapeutic potential. Pharmacol Ther 267:108803. https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108803","journal-title":"Pharmacol Ther"},{"key":"12920_CR15","doi-asserted-by":"publisher","first-page":"e20221720","DOI":"10.1084\/jem.20221720","volume":"220","author":"A Sandstrom","year":"2023","unstructured":"Sandstrom A (2023) NLRP1 activation by UVB: Shedding light on an enigmatic inflammasome. J Exp Med 220:e20221720. https:\/\/doi.org\/10.1084\/jem.20221720","journal-title":"J Exp Med"},{"key":"12920_CR16","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1093\/cvr\/cvab202","volume":"117","author":"Z On\u00f3di","year":"2021","unstructured":"On\u00f3di Z, Ruppert M, Kucsera D, Sayour AA, T\u00f3th VE, Koncsos G, Nov\u00e1k J, Brenner GB, Makkos A, Baranyai T, Giricz Z, G\u00f6rbe A, Leszek P, Gy\u00f6ngy\u00f6si M, Horv\u00e1th IG, Schulz R, Merkely B, Ferdinandy P, Radovits T, Varga ZV (2021) AIM2-driven inflammasome activation in heart failure. Cardiovasc Res 117:2639\u20132651. https:\/\/doi.org\/10.1093\/cvr\/cvab202","journal-title":"Cardiovasc Res"},{"key":"12920_CR17","doi-asserted-by":"publisher","first-page":"101085","DOI":"10.1016\/j.mam.2022.101085","volume":"88","author":"B Bibo-Verdugo","year":"2022","unstructured":"Bibo-Verdugo B, Salvesen GS (2022) Caspase mechanisms in the regulation of inflammation. Mol Aspects Med 88:101085. https:\/\/doi.org\/10.1016\/j.mam.2022.101085","journal-title":"Mol Aspects Med"},{"key":"12920_CR18","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1007\/s10495-024-01976-z","volume":"29","author":"E Svandova","year":"2024","unstructured":"Svandova E, Vesela B, Janeckova E, Chai Y, Matalova E (2024) Exploring caspase functions in mouse models. Apoptosis Int J Program Cell Death 29:938\u2013966. https:\/\/doi.org\/10.1007\/s10495-024-01976-z","journal-title":"Apoptosis Int J Program Cell Death"},{"key":"12920_CR19","doi-asserted-by":"publisher","first-page":"e3002103","DOI":"10.1371\/journal.pbio.3002103","volume":"21","author":"C Wang","year":"2023","unstructured":"Wang C, Ruan J (2023) An ancient defense mechanism: Conservation of gasdermin-mediated pyroptosis. PLoS Biol 21:e3002103. https:\/\/doi.org\/10.1371\/journal.pbio.3002103","journal-title":"PLoS Biol"},{"key":"12920_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41392-022-00991-3","volume":"7","author":"Z Qin","year":"2022","unstructured":"Qin Z, Zhou F, Zhang L (2022) Novel pyroptosis-independent functions of gasdermins. Signal Transduct Target Ther 7:127. https:\/\/doi.org\/10.1038\/s41392-022-00991-3","journal-title":"Signal Transduct Target Ther"},{"key":"12920_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s43556-025-00249-8","volume":"6","author":"Y Li","year":"2025","unstructured":"Li Y, Guo B (2025) GSDMD-mediated pyroptosis: molecular mechanisms, diseases and therapeutic targets. Mol Biomed 6:11. https:\/\/doi.org\/10.1186\/s43556-025-00249-8","journal-title":"Mol Biomed"},{"key":"12920_CR22","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41590-023-01526-w","volume":"24","author":"P Devant","year":"2023","unstructured":"Devant P, Kagan JC (2023) Molecular mechanisms of gasdermin D pore-forming activity. Nat Immunol 24:1064\u20131075. https:\/\/doi.org\/10.1038\/s41590-023-01526-w","journal-title":"Nat Immunol"},{"key":"12920_CR23","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.tcb.2021.03.004","volume":"31","author":"E De Schutter","year":"2021","unstructured":"De Schutter E, Roelandt R, Riquet FB, Van Camp G, Wullaert A, Vandenabeele P (2021) Punching Holes in Cellular Membranes: Biology and Evolution of Gasdermins. Trends Cell Biol 31:500\u2013513. https:\/\/doi.org\/10.1016\/j.tcb.2021.03.004","journal-title":"Trends Cell Biol"},{"key":"12920_CR24","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41586-022-04825-8","volume":"606","author":"K Nozaki","year":"2022","unstructured":"Nozaki K, Maltez VI, Rayamajhi M, Tubbs AL, Mitchell JE, Lacey CA, Harvest CK, Li L, Nash WT, Larson HN, McGlaughon BD, Moorman NJ, Brown MG, Whitmire JK, Miao EA (2022) Caspase-7 activates ASM to repair gasdermin and perforin pores. Nature 606:960\u2013967. https:\/\/doi.org\/10.1038\/s41586-022-04825-8","journal-title":"Nature"},{"key":"12920_CR25","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2023.04.025","volume":"186","author":"KC Barnett","year":"2023","unstructured":"Barnett KC, Li S, Liang K, Ting JPY (2023) A 360\u00b0 view of the inflammasome: mechanisms of activation, cell death, and diseases. Cell 186:2288\u20132312. https:\/\/doi.org\/10.1016\/j.cell.2023.04.025","journal-title":"Cell"},{"key":"12920_CR26","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1172\/JCI136908","volume":"130","author":"S Xiong","year":"2020","unstructured":"Xiong S, Hong Z, Huang LS, Tsukasaki Y, Nepal S, Di A, Zhong M, Wu W, Ye Z, Gao X, Rao GN, Mehta D, Rehman J, Malik AB (2020) IL-1\u03b2 suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury. J Clin Invest 130:3684\u20133698. https:\/\/doi.org\/10.1172\/JCI136908","journal-title":"J Clin Invest"},{"key":"12920_CR27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-025-00837-0","volume":"26","author":"Y Bai","year":"2025","unstructured":"Bai Y, Pan Y, Liu X (2025) Mechanistic insights into gasdermin-mediated pyroptosis. Nat Rev Mol Cell Biol 26:501\u2013521. https:\/\/doi.org\/10.1038\/s41580-025-00837-0","journal-title":"Nat Rev Mol Cell Biol"},{"key":"12920_CR28","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1016\/j.molcel.2021.09.003","volume":"81","author":"J Hou","year":"2021","unstructured":"Hou J, Hsu JM, Hung MC (2021) Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity. Mol Cell 81:4579\u20134590. https:\/\/doi.org\/10.1016\/j.molcel.2021.09.003","journal-title":"Mol Cell"},{"key":"12920_CR29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki N, Stowe IB, Lee BL, O\u2019Rourke K, Anderson K, Warming S, Cuellar T, Haley B, Roose-Girma M, Phung QT, Liu PS, Lill JR, Li H, Wu J, Kummerfeld S, Zhang J, Lee WP, Snipas SJ, Salvesen GS, Morris LX, Fitzgerald L, Zhang Y, Bertram EM, Goodnow CC, Dixit VM (2015) Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526:666\u2013671. https:\/\/doi.org\/10.1038\/nature15541","journal-title":"Nature"},{"key":"12920_CR30","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1172\/JCI94495","volume":"127","author":"KT Cheng","year":"2017","unstructured":"Cheng KT, Xiong S, Ye Z, Hong Z, Di A, Tsang KM, Gao X, An S, Mittal M, Vogel SM, Miao EA, Rehman J, Malik AB (2017) Caspase-11-mediated endothelial pyroptosis underlies endotoxemia-induced lung injury. J Clin Invest 127:4124\u20134135. https:\/\/doi.org\/10.1172\/JCI94495","journal-title":"J Clin Invest"},{"key":"12920_CR31","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.immuni.2019.11.005","volume":"51","author":"X Yang","year":"2019","unstructured":"Yang X, Cheng X, Tang Y, Qiu X, Wang Y, Kang H, Wu J, Wang Z, Liu Y, Chen F, Xiao X, Mackman N, Billiar TR, Han J, Lu B (2019) Bacterial endotoxin activates the coagulation cascade through gasdermin D-dependent phosphatidylserine exposure. Immunity 51:983\u2013996e6. https:\/\/doi.org\/10.1016\/j.immuni.2019.11.005","journal-title":"Immunity"},{"key":"12920_CR32","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/ijms25020962","volume":"25","author":"S Cicchinelli","year":"2024","unstructured":"Cicchinelli S, Pignataro G, Gemma S, Piccioni A, Picozzi D, Ojetti V, Franceschi F, Candelli M (2024) PAMPs and DAMPs in sepsis: a review of their molecular features and potential clinical implications. Int J Mol Sci 25:962. https:\/\/doi.org\/10.3390\/ijms25020962","journal-title":"Int J Mol Sci"},{"key":"12920_CR33","doi-asserted-by":"publisher","first-page":"e20201707","DOI":"10.1084\/jem.20201707","volume":"218","author":"TS Rodrigues","year":"2021","unstructured":"Rodrigues TS, de S\u00e1 KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, Gon\u00e7alves AV, Perucello DB, Andrade WA, Castro R, Veras FP, Toller-Kawahisa JE, Nascimento DC, de Lima MHF, Silva CMS, Caetite DB, Martins RB, Castro IA, Pontelli MC, de Barros FC, do Amaral NB, Giannini MC, Bonjorno LP, Lopes MIF, Santana RC, Vilar FC, Auxiliadora-Martins M, Luppino-Assad R, de Almeida SCL, de Oliveira FR, Batah SS, L S, Benatti MN, Cunha TM, Alves-Filho JC, Cunha FQ, Cunha LD, Frantz FG, Kohlsdorf T, Fabro AT, Arruda E, de Oliveira RDR, Louzada-Junior P, Zamboni DS (2021) Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med 218:e20201707. https:\/\/doi.org\/10.1084\/jem.20201707","journal-title":"J Exp Med"},{"key":"12920_CR34","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","volume":"606","author":"C Junqueira","year":"2022","unstructured":"Junqueira C, Crespo \u00c2, Ranjbar S, de Lacerda LB, Lewandrowski M, Ingber J, Parry B, Ravid S, Clark S, Schrimpf MR, Ho F, Beakes C, Margolin J, Russell N, Kays K, Boucau J, Das Adhikari U, Vora SM, Leger V, Gehrke L, Henderson LA, Janssen E, Kwon D, Sander C, Abraham J, Goldberg MB, Wu H, Mehta G, Bell S, Goldfeld AE, Filbin MR, Lieberman J (2022) Fc\u03b3R-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 606:576\u2013584. https:\/\/doi.org\/10.1038\/s41586-022-04702-4","journal-title":"Nature"},{"key":"12920_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.chom.2022.12.005","volume":"31","author":"KC Barnett","year":"2023","unstructured":"Barnett KC, Xie Y, Asakura T, Song D, Liang K, Taft-Benz SA, Guo H, Yang S, Okuda K, Gilmore RC, Loome JF, Oguin Iii TH, Sempowski GD, Randell SH, Heise MT, Lei YL, Boucher RC, Ting JPY (2023) An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2. Cell Host Microbe 31:243\u2013259e6. https:\/\/doi.org\/10.1016\/j.chom.2022.12.005","journal-title":"Cell Host Microbe"},{"key":"12920_CR36","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41577-021-00588-x","volume":"21","author":"SM Vora","year":"2021","unstructured":"Vora SM, Lieberman J, Wu H (2021) Inflammasome activation at the crux of severe COVID-19. Nat Rev Immunol 21:694\u2013703. https:\/\/doi.org\/10.1038\/s41577-021-00588-x","journal-title":"Nat Rev Immunol"},{"key":"12920_CR37","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1161\/ATVBAHA.121.316925","volume":"41","author":"S Xiong","year":"2021","unstructured":"Xiong S, Zhang L, Richner JM, Class J, Rehman J, Malik AB (2021) Interleukin-1RA mitigates SARS-CoV-2-induced inflammatory lung vascular leakage and mortality in humanized K18-hACE-2 mice. Arterioscler Thromb Vasc Biol 41:2773\u20132785. https:\/\/doi.org\/10.1161\/ATVBAHA.121.316925","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"12920_CR38","doi-asserted-by":"publisher","first-page":"110420","DOI":"10.1016\/j.cellsig.2022.110420","volume":"99","author":"Y Tang","year":"2022","unstructured":"Tang Y, Yan JH, Ge ZW, Fei AH, Zhang YC (2022) LncRNA gaplinc promotes the pyroptosis of vascular endothelial cells through SP1 binding to enhance NLRP3 transcription in atherosclerosis. Cell Signal 99:110420. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110420","journal-title":"Cell Signal"},{"key":"12920_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.metabol.2017.06.002","volume":"74","author":"J Rheinheimer","year":"2017","unstructured":"Rheinheimer J, de Souza BM, Cardoso NS, Bauer AC, Crispim D (2017) Current role of the NLRP3 inflammasome on obesity and insulin resistance: a systematic review. Metabolism 74:1\u20139. https:\/\/doi.org\/10.1016\/j.metabol.2017.06.002","journal-title":"Metabolism"},{"key":"12920_CR40","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2017.11.040","volume":"68","author":"B Xu","year":"2018","unstructured":"Xu B, Jiang M, Chu Y, Wang W, Chen D, Li X, Zhang Z, Zhang D, Fan D, Nie Y, Shao F, Wu K, Liang J (2018) Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. J Hepatol 68:773\u2013782. https:\/\/doi.org\/10.1016\/j.jhep.2017.11.040","journal-title":"J Hepatol"},{"key":"12920_CR41","doi-asserted-by":"publisher","first-page":"1583886","DOI":"10.3389\/fimmu.2025.1583886","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z, Gong C (2025) NLRP3 inflammasome in alzheimer\u2019s disease: molecular mechanisms and emerging therapies. Front Immunol 16:1583886. https:\/\/doi.org\/10.3389\/fimmu.2025.1583886","journal-title":"Front Immunol"},{"key":"12920_CR42","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, Schwartz S, Albasset S, McManus RM, Tejera D, Griep A, Santarelli F, Brosseron F, Opitz S, Stunden J, Merten M, Kayed R, Golenbock DT, Blum D, Latz E, Bu\u00e9e L, Heneka MT (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575:669\u2013673. https:\/\/doi.org\/10.1038\/s41586-019-1769-z","journal-title":"Nature"},{"key":"12920_CR43","doi-asserted-by":"publisher","first-page":"eaah4066","DOI":"10.1126\/scitranslmed.aah4066","volume":"10","author":"R Gordon","year":"2018","unstructured":"Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S, Robertson AAB, Butler MS, Rowe DB, O\u2019Neill LA, Kanthasamy AG, Schroder K, Cooper MA, Woodruff TM (2018) Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med 10:eaah4066. https:\/\/doi.org\/10.1126\/scitranslmed.aah4066","journal-title":"Sci Transl Med"},{"key":"12920_CR44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, B\u00fcning C, Cohain A, Cichon S, D\u2019Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H, Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH, International Ibd Genetics Consortium (Iibdgc) (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119\u2013124. https:\/\/doi.org\/10.1038\/nature11582","journal-title":"Nature"},{"key":"12920_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tcb.2022.06.006","volume":"33","author":"AI Ivanov","year":"2023","unstructured":"Ivanov AI, Rana N, Privitera G, Pizarro TT (2023) The enigmatic roles of epithelial gasdermin B: recent discoveries and controversies. Trends Cell Biol 33:48\u201359. https:\/\/doi.org\/10.1016\/j.tcb.2022.06.006","journal-title":"Trends Cell Biol"},{"key":"12920_CR46","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1016\/j.cell.2023.05.027","volume":"186","author":"D Gasdermin","year":"2023","unstructured":"Gasdermin D (2023) licenses MHCII induction to maintain food tolerance in small intestine. Cell 186:3033\u20133048e20. https:\/\/doi.org\/10.1016\/j.cell.2023.05.027","journal-title":"Cell"},{"key":"12920_CR47","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41577-024-01027-3","volume":"24","author":"Y Huang","year":"2024","unstructured":"Huang Y, Jiang W, Zhou R (2024) DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways. Nat Rev Immunol 24:703\u2013719. https:\/\/doi.org\/10.1038\/s41577-024-01027-3","journal-title":"Nat Rev Immunol"},{"key":"12920_CR48","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-021-03875-8","volume":"597","author":"S Lee","year":"2021","unstructured":"Lee S, Karki R, Wang Y, Nguyen LN, Kalathur RC, Kanneganti TD (2021) AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature 597:415\u2013419. https:\/\/doi.org\/10.1038\/s41586-021-03875-8","journal-title":"Nature"},{"key":"12920_CR49","doi-asserted-by":"publisher","unstructured":"Br RK, Ep SST, L Z W, M Z PS, Rks BSBB, Cb MPSGNPVRW, Td J K (2021) Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell 184. https:\/\/doi.org\/10.1016\/j.cell.2020.11.025","DOI":"10.1016\/j.cell.2020.11.025"},{"key":"12920_CR50","doi-asserted-by":"publisher","unstructured":"Df AG, La BSNTZIS, de V V, B JGVM, Da T, Kq R, C C, Rm YDSJBCD, Md WMSBLDZ, Al ASLRB, Jc D, C CPV, Lc LMS, Dr F, Gd G, Pg C T, A D, S B (2024) Necroptosis blockade prevents lung injury in severe influenza. Nature 628. https:\/\/doi.org\/10.1038\/s41586-024-07265-8","DOI":"10.1038\/s41586-024-07265-8"},{"key":"12920_CR51","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41467-023-35917-2","volume":"14","author":"J Lin","year":"2023","unstructured":"Lin J, Sun S, Zhao K, Gao F, Wang R, Li Q, Zhou Y, Zhang J, Li Y, Wang X, Du L, Wang S, Li Z, Lu H, Lan Y, Song D, Guo W, Chen Y, Gao F, Zhao Y, Fan R, Guan J, He W (2023) Oncolytic Parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity. Nat Commun 14:224. https:\/\/doi.org\/10.1038\/s41467-023-35917-2","journal-title":"Nat Commun"},{"key":"12920_CR52","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1053\/j.gastro.2022.01.004","volume":"162","author":"J Schw\u00e4rzler","year":"2022","unstructured":"Schw\u00e4rzler J, Mayr L, Vich Vila A, Grabherr F, Niederreiter L, Philipp M, Grander C, Meyer M, Jukic A, Tr\u00f6ger S, Enrich B, Przysiecki N, Tschurtschenthaler M, Sommer F, Kronberger I, Koch J, Hilbe R, Hess MW, Oberhuber G, Sprung S, Ran Q, Koch R, Effenberger M, Kaneider NC, Wieser V, Keller MA, Weersma RK, Aden K, Rosenstiel P, Blumberg RS, Kaser A, Tilg H, Adolph TE (2022) PUFA-induced metabolic enteritis as a fuel for crohn\u2019s disease. Gastroenterology 162:1690\u20131704. https:\/\/doi.org\/10.1053\/j.gastro.2022.01.004","journal-title":"Gastroenterology"},{"key":"12920_CR53","doi-asserted-by":"publisher","first-page":"833588","DOI":"10.3389\/fphar.2022.833588","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Liang Y, Yao J, Li DF, Wang LS (2022) Role of Pyroptosis in Inflammatory Bowel Disease (IBD): From Gasdermins to DAMPs. Front Pharmacol 13:833588. https:\/\/doi.org\/10.3389\/fphar.2022.833588","journal-title":"Front Pharmacol"},{"key":"12920_CR54","doi-asserted-by":"publisher","first-page":"109265","DOI":"10.1016\/j.celrep.2021.109265","volume":"35","author":"G Tan","year":"2021","unstructured":"Tan G, Huang C, Chen J, Chen B, Zhi F (2021) Gasdermin-E-mediated pyroptosis participates in the pathogenesis of Crohn\u2019s disease by promoting intestinal inflammation. Cell Rep 35:109265. https:\/\/doi.org\/10.1016\/j.celrep.2021.109265","journal-title":"Cell Rep"},{"key":"12920_CR55","doi-asserted-by":"publisher","first-page":"101625","DOI":"10.1016\/j.jcmgh.2025.101625","volume":"20","author":"S Li","year":"2025","unstructured":"Li S, Zhu F, Xie Y, Ben T, Liu K, Lin X, Zhou Q, Zhang Y, Zhang X, Chen Y, Ren Y, Wang X, Zhi F, Tan G (2025) Imperatorin Alleviates Intestinal Fibrosis by Suppressing AIM2-mediated GSDMD Pyroptosis in Macrophages. Cell Mol Gastroenterol Hepatol 20:101625. https:\/\/doi.org\/10.1016\/j.jcmgh.2025.101625","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"12920_CR56","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s10753-024-02025-2","volume":"47","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Ma Y, Pei J, Zhao X, Jiang Y, Liu Q (2024) Exploring Pyroptosis-related Signature Genes and Potential Drugs in Ulcerative Colitis by Transcriptome Data and Animal Experimental Validation. Inflammation 47:2057\u20132076. https:\/\/doi.org\/10.1007\/s10753-024-02025-2","journal-title":"Inflammation"},{"key":"12920_CR57","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1038\/s41401-025-01549-z","volume":"46","author":"J Wang","year":"2025","unstructured":"Wang J, Zhang C, Qin J, An N, Bai M, Du RH, Shen Y, Wu XD, Cheng JC, Wu XF, Xu Q (2025) Direct inhibition of the TXNIP-NLRP3-GSDMD pathway reduces pyroptosis in colonocytes and alleviates ulcerative colitis in mice by the small compound PEITC. Acta Pharmacol Sin 46:2436\u20132449. https:\/\/doi.org\/10.1038\/s41401-025-01549-z","journal-title":"Acta Pharmacol Sin"},{"key":"12920_CR58","doi-asserted-by":"publisher","first-page":"16658","DOI":"10.1021\/acsnano.4c01520","volume":"18","author":"W Li","year":"2024","unstructured":"Li W, Chen D, Zhu Y, Ye Q, Hua Y, Jiang P, Xiang Y, Xu Y, Pan Y, Yang H, Ma Y, Xu H, Zhao C, Zheng C, Chen C, Zhu Y, Xu G (2024) Alleviating Pyroptosis of Intestinal Epithelial Cells to Restore Mucosal Integrity in Ulcerative Colitis by Targeting Delivery of 4-Octyl-Itaconate. ACS Nano 18:16658\u201316673. https:\/\/doi.org\/10.1021\/acsnano.4c01520","journal-title":"ACS Nano"},{"key":"12920_CR59","doi-asserted-by":"publisher","first-page":"2163838","DOI":"10.1080\/19490976.2022.2163838","volume":"15","author":"R Singh","year":"2023","unstructured":"Singh R, Rossini V, Stockdale SR, Saiz-Gonzalo G, Hanrahan N, D\u2019 Souza T, Clooney A, Draper LA, Hill C, Nally K, Shanahan F, Andersson-Engels S, Melgar S (2023) An IBD-associated pathobiont synergises with NSAID to promote colitis which is blocked by NLRP3 inflammasome and Caspase-8 inhibitors. Gut Microbes 15:2163838. https:\/\/doi.org\/10.1080\/19490976.2022.2163838","journal-title":"Gut Microbes"},{"key":"12920_CR60","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1172\/JCI138103","volume":"130","author":"K Bulek","year":"2020","unstructured":"Bulek K, Zhao J, Liao Y, Rana N, Corridoni D, Antanaviciute A, Chen X, Wang H, Qian W, Miller-Little WA, Swaidani S, Tang F, Willard BB, McCrae K, Kang Z, Dubyak GR, Cominelli F, Simmons A, Pizarro TT, Li X (2020) Epithelial-derived gasdermin D mediates nonlytic IL-1\u03b2 release during experimental colitis. J Clin Invest 130:4218\u20134234. https:\/\/doi.org\/10.1172\/JCI138103","journal-title":"J Clin Invest"},{"key":"12920_CR61","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cell.2021.12.024","volume":"185","author":"N Rana","year":"2022","unstructured":"Rana N, Privitera G, Kondolf HC, Bulek K, Lechuga S, De Salvo C, Corridoni D, Antanaviciute A, Maywald RL, Hurtado AM, Zhao J, Huang EH, Li X, Chan ER, Simmons A, Bamias G, Abbott DW, Heaney JD, Ivanov AI, Pizarro TT (2022) GSDMB is increased in IBD and regulates epithelial restitution\/repair independent of pyroptosis. Cell 185:283\u2013298e17. https:\/\/doi.org\/10.1016\/j.cell.2021.12.024","journal-title":"Cell"},{"key":"12920_CR62","doi-asserted-by":"publisher","first-page":"105739","DOI":"10.1016\/j.ebiom.2025.105739","volume":"116","author":"ML Ji","year":"2025","unstructured":"Ji ML, Wang JN, Wu MF, Xu CH, Zhang MM, Chang WB, Mao XF, Li C, Yu JT, Zhang DF, Suo XG, Diao SX, Ma NN, Chen Y, Hou R, Lu H, Xie SS, Dong YH, Zhu Q, Chen X, Xu T, Shao W, Jin J, Wen JG, Dong XW, Wang WB, Che JX, Meng XM (2025) Targeting Stat3 with conditional knockout or PROTAC technology alleviates renal injury by Limiting pyroptosis. eBioMedicine 116:105739. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105739","journal-title":"eBioMedicine"},{"key":"12920_CR63","doi-asserted-by":"publisher","first-page":"157041","DOI":"10.1016\/j.phymed.2025.157041","volume":"145","author":"D Zhu","year":"2025","unstructured":"Zhu D, Zhao Q, Pan T, Bai L, Zhao Y, Wang J, Wang Z, Xu Y, Zhou X (2025) Maiwei Yangfei decoction protects against pulmonary fibrosis by suppressing NLRP3 inflammasome-mediated pyroptosis of alveolar macrophage. Phytomedicine 145:157041. https:\/\/doi.org\/10.1016\/j.phymed.2025.157041","journal-title":"Phytomedicine"},{"key":"12920_CR64","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s10495-025-02151-8","volume":"30","author":"Y Hu","year":"2025","unstructured":"Hu Y, Huang Y, Guo J, Liu X, Liu Y (2025) Targeting pyroptosis in myocardial inflammation and fibrosis: molecular mechanisms and therapeutic strategies. Apoptosis Int J Program Cell Death 30:1989\u20132007. https:\/\/doi.org\/10.1007\/s10495-025-02151-8","journal-title":"Apoptosis Int J Program Cell Death"},{"key":"12920_CR65","doi-asserted-by":"publisher","first-page":"1338125","DOI":"10.3389\/fimmu.2024.1338125","volume":"15","author":"L Ni","year":"2024","unstructured":"Ni L, Chen D, Zhao Y, Ye R, Fang P (2024) Unveiling the flames: macrophage pyroptosis and its crucial role in liver diseases. Front Immunol 15:1338125. https:\/\/doi.org\/10.3389\/fimmu.2024.1338125","journal-title":"Front Immunol"},{"key":"12920_CR66","doi-asserted-by":"publisher","first-page":"117177","DOI":"10.1016\/j.bcp.2025.117177","volume":"241","author":"R Wang","year":"2025","unstructured":"Wang R, Wang M, Chen J, Sun M, Zhao P, Zheng X, Li D, Long C, Shen L, Wei G, Wu S (2025) Targeting STING alleviates pyroptosis of bladder epithelial cells and ameliorates bladder fibrosis in neurogenic bladder. Biochem Pharmacol 241:117177. https:\/\/doi.org\/10.1016\/j.bcp.2025.117177","journal-title":"Biochem Pharmacol"},{"key":"12920_CR67","doi-asserted-by":"publisher","unstructured":"Zheng Y, Zhang X, Wang Z, Zhang R, Wei H, Yan X, Jiang X, Yang L (2024) MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions. Arch Pharm (Weinheim) 357e2400459. https:\/\/doi.org\/10.1002\/ardp.202400459","DOI":"10.1002\/ardp.202400459"},{"key":"12920_CR68","doi-asserted-by":"publisher","first-page":"117711","DOI":"10.1016\/j.biopha.2024.117711","volume":"181","author":"S Li","year":"2024","unstructured":"Li S, Withaar C, Rodrigues PG, Zijlstra SN, de Boer RA, Sillj\u00e9 HHW, Meems LMG (2024) The NLRP3-inflammasome inhibitor MCC950 improves cardiac function in a HFpEF mouse model. Biomed Pharmacother Biomedecine Pharmacother 181:117711. https:\/\/doi.org\/10.1016\/j.biopha.2024.117711","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"12920_CR69","doi-asserted-by":"publisher","first-page":"116261","DOI":"10.1016\/j.biopha.2024.116261","volume":"172","author":"X Wu","year":"2024","unstructured":"Wu X, Yang J, Wu J, Yang X (2024) Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome in systemic lupus erythematosus. Biomed Pharmacother Biomedecine Pharmacother 172:116261. https:\/\/doi.org\/10.1016\/j.biopha.2024.116261","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"12920_CR70","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1124\/pharmrev.120.000171","volume":"73","author":"SE Corcoran","year":"2021","unstructured":"Corcoran SE, Halai R, Cooper MA (2021) Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950. Pharmacol Rev 73:968\u20131000. https:\/\/doi.org\/10.1124\/pharmrev.120.000171","journal-title":"Pharmacol Rev"},{"key":"12920_CR71","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1084\/jem.20171419","volume":"214","author":"H Jiang","year":"2017","unstructured":"Jiang H, He H, Chen Y, Huang W, Cheng J, Ye J, Wang A, Tao J, Wang C, Liu Q, Jin T, Jiang W, Deng X, Zhou R (2017) Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J Exp Med 214:3219\u20133238. https:\/\/doi.org\/10.1084\/jem.20171419","journal-title":"J Exp Med"},{"key":"12920_CR72","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/FJC.0000000000000931","volume":"77","author":"GF Wohlford","year":"2020","unstructured":"Wohlford GF, Van Tassell BW, Billingsley HE, Kadariya D, Canada JM, Carbone S, Mihalick VL, Bonaventura A, Vecchi\u00e9 A, Chiabrando JG, Bressi E, Thomas G, Ho AC, Marawan AA, Dell M, Trankle CR, Turlington J, Markley R, Abbate A (2020) Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart Failure. J Cardiovasc Pharmacol 77:49\u201360. https:\/\/doi.org\/10.1097\/FJC.0000000000000931","journal-title":"J Cardiovasc Pharmacol"},{"key":"12920_CR73","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/s2665-9913(20)30065-5","volume":"2","author":"V Kl\u00fcck","year":"2020","unstructured":"Kl\u00fcck V, Jansen TLTA, Janssen M, Comarniceanu A, Efd\u00e9 M, Tengesdal IW, Schraa K, Cleophas MCP, Scribner CL, Skouras DB, Marchetti C, Dinarello CA, Joosten LAB (2020) Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol 2:e270\u2013e280. https:\/\/doi.org\/10.1016\/s2665-9913(20)30065-5","journal-title":"Lancet Rheumatol"},{"key":"12920_CR74","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s15010-022-01904-w","volume":"51","author":"I Madurka","year":"2023","unstructured":"Madurka I, Vishnevsky A, Soriano JB, Gans SJ, Ore DJS, Rendon A, Ulrik CS, Bhatnagar S, Krishnamurthy S, Mc Harry K, Welte T, Fernandez AA, Mehes B, Meiser K, Gatlik E, Sommer U, Junge G, Rezende E, Study group (2023) DFV890: a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function. Infection 51:641\u2013654. https:\/\/doi.org\/10.1007\/s15010-022-01904-w","journal-title":"Infection"},{"key":"12920_CR75","doi-asserted-by":"publisher","first-page":"14897","DOI":"10.1021\/acs.jmedchem.3c01398","volume":"66","author":"D Harrison","year":"2023","unstructured":"Harrison D, Billinton A, Bock MG, Doedens JR, Gabel CA, Holloway MK, Porter RA, Reader V, Scanlon J, Schooley K, Watt AP (2023) Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders. J Med Chem 66:14897\u201314911. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01398","journal-title":"J Med Chem"},{"key":"12920_CR76","doi-asserted-by":"publisher","first-page":"e1471","DOI":"10.1002\/ctm2.1471","volume":"13","author":"B Klughammer","year":"2023","unstructured":"Klughammer B, Piali L, Nica A, Nagel S, Bailey L, Jochum C, Ignatenko S, Bl\u00e4uer A, Danilin S, Gulati P, Hayward J, Scepanovic P, Zhang JD, Bhosale S, Chong CF, Christ A (2023) A randomized, double-blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to severe active ulcerative colitis. Clin Transl Med 13:e1471. https:\/\/doi.org\/10.1002\/ctm2.1471","journal-title":"Clin Transl Med"},{"key":"12920_CR77","doi-asserted-by":"publisher","first-page":"e8689","DOI":"10.15252\/emmm.201708689","volume":"10","author":"Y Huang","year":"2018","unstructured":"Huang Y, Jiang H, Chen Y, Wang X, Yang Y, Tao J, Deng X, Liang G, Zhang H, Jiang W, Zhou R (2018) Tranilast directly targets NLRP3 to treat inflammasome-driven diseases. EMBO Mol Med 10:e8689. https:\/\/doi.org\/10.15252\/emmm.201708689","journal-title":"EMBO Mol Med"},{"key":"12920_CR78","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","volume":"9","author":"H He","year":"2018","unstructured":"He H, Jiang H, Chen Y, Ye J, Wang A, Wang C, Liu Q, Liang G, Deng X, Jiang W, Zhou R (2018) Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat Commun 9:2550. https:\/\/doi.org\/10.1038\/s41467-018-04947-6","journal-title":"Nat Commun"},{"key":"12920_CR79","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1080\/15548627.2023.2187957","volume":"19","author":"L Wang","year":"2023","unstructured":"Wang L, Cui J (2023) Palmitoylation promotes chaperone-mediated autophagic degradation of NLRP3 to modulate inflammation. Autophagy 19:2821\u20132823. https:\/\/doi.org\/10.1080\/15548627.2023.2187957","journal-title":"Autophagy"},{"key":"12920_CR80","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.7150\/ijbs.86869","volume":"19","author":"H Jiang","year":"2023","unstructured":"Jiang H, Liu P, Kang J, Wu J, Gong W, Li X, Li Y, Liu J, Li W, Ni C, Liao B, Wu X, Zhao Y, Ren J (2023) Precise Orchestration of Gasdermins\u2019 Pore-Forming Function by Posttranslational Modifications in Health and Disease. Int J Biol Sci 19:4931\u20134947. https:\/\/doi.org\/10.7150\/ijbs.86869","journal-title":"Int J Biol Sci"},{"key":"12920_CR81","doi-asserted-by":"publisher","first-page":"eadn1452","DOI":"10.1126\/sciimmunol.adn1452","volume":"9","author":"A Balasubramanian","year":"2024","unstructured":"Balasubramanian A, Hsu AY, Ghimire L, Tahir M, Devant P, Fontana P, Du G, Liu X, Fabin D, Kambara H, Xie X, Liu F, Hasegawa T, Xu R, Yu H, Chen M, Kolakowski S, Trauger S, Larsen MR, Wei W, Wu H, Kagan JC, Lieberman J, Luo HR (2024) The palmitoylation of gasdermin D directs its membrane translocation and pore formation during pyroptosis. Sci Immunol 9:eadn1452. https:\/\/doi.org\/10.1126\/sciimmunol.adn1452","journal-title":"Sci Immunol"},{"key":"12920_CR82","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-024-07373-5","volume":"630","author":"G Du","year":"2024","unstructured":"Du G, Healy LB, David L, Walker C, El-Baba TJ, Lutomski CA, Goh B, Gu B, Pi X, Devant P, Fontana P, Dong Y, Ma X, Miao R, Balasubramanian A, Puthenveetil R, Banerjee A, Luo HR, Kagan JC, Oh SF, Robinson CV, Lieberman J, Wu H (2024) ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D. Nature 630:437\u2013446. https:\/\/doi.org\/10.1038\/s41586-024-07373-5","journal-title":"Nature"},{"key":"12920_CR83","doi-asserted-by":"publisher","first-page":"114187","DOI":"10.1016\/j.intimp.2025.114187","volume":"149","author":"Y Shi","year":"2025","unstructured":"Shi Y, Li X, Xu W, Wang Y, Dong L, Li D, He S, Yang Y, Chen N, Fu X, Shi F (2025) SUMOylation regulates GSDMD stability and pyroptosis. Int Immunopharmacol 149:114187. https:\/\/doi.org\/10.1016\/j.intimp.2025.114187","journal-title":"Int Immunopharmacol"},{"key":"12920_CR84","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41419-025-07475-6","volume":"16","author":"X Chu","year":"2025","unstructured":"Chu X, Zhang T, Bukhari I, Hu M, Xu J, Xing Y, Liang X, Zhang Z, Zheng P (2025) Ubiquitination of gasdermin D N-terminal domain directs its membrane translocation and pore formation during pyroptosis. Cell Death Dis 16:181. https:\/\/doi.org\/10.1038\/s41419-025-07475-6","journal-title":"Cell Death Dis"},{"key":"12920_CR85","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.7150\/ijbs.111867","volume":"21","author":"SK Hsu","year":"2025","unstructured":"Hsu SK, Kuo IY, Lin PY, Chou CK, Ko CC, Chang WT, Chiu CC (2025) Deubiquitinating enzymes: Key regulators of ferroptosis and pyroptosis and novel targets for cancer intervention. Int J Biol Sci 21:3993\u20134009. https:\/\/doi.org\/10.7150\/ijbs.111867","journal-title":"Int J Biol Sci"},{"key":"12920_CR86","doi-asserted-by":"publisher","first-page":"eaat2738","DOI":"10.1126\/sciimmunol.aat2738","volume":"3","author":"JK Rathkey","year":"2018","unstructured":"Rathkey JK, Zhao J, Liu Z, Chen Y, Yang J, Kondolf HC, Benson BL, Chirieleison SM, Huang AY, Dubyak GR, Xiao TS, Li X, Abbott DW (2018) Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis. Sci Immunol 3:eaat2738. https:\/\/doi.org\/10.1126\/sciimmunol.aat2738","journal-title":"Sci Immunol"},{"key":"12920_CR87","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","volume":"43","author":"RC Coll","year":"2022","unstructured":"Coll RC, Schroder K, Pelegr\u00edn P (2022) NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol Sci 43:653\u2013668. https:\/\/doi.org\/10.1016\/j.tips.2022.04.003","journal-title":"Trends Pharmacol Sci"},{"key":"12920_CR88","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S1474-4422(22)00209-5","volume":"21","author":"A Svenningsson","year":"2022","unstructured":"Svenningsson A, Frisell T, Burman J, Salzer J, Fink K, Hallberg S, Hambraeus J, Axelsson M, Nimer FA, Sundstr\u00f6m P, Gunnarsson M, Johansson R, Mellerg\u00e5rd J, Rosenstein I, Ayad A, Sj\u00f6blom I, Risedal A, de Flon P, Gilland E, Lindeberg J, Shawket F, Piehl F, Lycke J (2022) Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial. Lancet Neurol 21:693\u2013703. https:\/\/doi.org\/10.1016\/S1474-4422(22)00209-5","journal-title":"Lancet Neurol"},{"key":"12920_CR89","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/antiox9040354","volume":"9","author":"S Li","year":"2020","unstructured":"Li S, Takasu C, Lau H, Robles L, Vo K, Farzaneh T, Vaziri ND, Stamos MJ, Ichii H (2020) Dimethyl Fumarate Alleviates Dextran Sulfate Sodium-Induced Colitis, through the Activation of Nrf2-Mediated Antioxidant and Anti-inflammatory Pathways. Antioxid Basel Switz 9:354. https:\/\/doi.org\/10.3390\/antiox9040354","journal-title":"Antioxid Basel Switz"},{"key":"12920_CR90","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","volume":"21","author":"JJ Hu","year":"2020","unstructured":"Hu JJ, Liu X, Xia S, Zhang Z, Zhang Y, Zhao J, Ruan J, Luo X, Lou X, Bai Y, Wang J, Hollingsworth LR, Magupalli VG, Zhao L, Luo HR, Kim J, Lieberman J, Wu H (2020) FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol 21:736\u2013745. https:\/\/doi.org\/10.1038\/s41590-020-0669-6","journal-title":"Nat Immunol"},{"key":"12920_CR91","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.ijrobp.2024.05.009","volume":"120","author":"J Huang","year":"2024","unstructured":"Huang J, Campian JL, DeWees TA, Skrott Z, Mistrik M, Johanns TM, Ansstas G, Butt O, Leuthardt E, Dunn GP, Zipfel GJ, Osbun JW, Abraham C, Badiyan S, Schwetye K, Cairncross JG, Rubin JB, Kim AH, Chheda MG (2024) A Phase 1\/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma. Int J Radiat Oncol Biol Phys 120:738\u2013749. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.05.009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"12920_CR92","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41423-024-01131-3","volume":"21","author":"ZD Zhang","year":"2024","unstructured":"Zhang ZD, Shi CR, Li FX, Gan H, Wei Y, Zhang Q, Shuai X, Chen M, Lin YL, Xiong TC, Chen X, Zhong B, Lin D (2024) Disulfiram ameliorates STING\/MITA-dependent inflammation and autoimmunity by targeting RNF115. Cell Mol Immunol 21:275\u2013291. https:\/\/doi.org\/10.1038\/s41423-024-01131-3","journal-title":"Cell Mol Immunol"},{"key":"12920_CR93","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.7150\/thno.81571","volume":"13","author":"W Zhou","year":"2023","unstructured":"Zhou W, Zhang H, Huang L, Sun C, Yue Y, Cao X, Jia H, Wang C, Gao Y (2023) Disulfiram with Cu2\u2009+\u2009alleviates dextran sulfate sodium-induced ulcerative colitis in mice. Theranostics 13:2879\u20132895. https:\/\/doi.org\/10.7150\/thno.81571","journal-title":"Theranostics"},{"key":"12920_CR94","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1002\/mds.30307","volume":"40","author":"N Clarke","year":"2025","unstructured":"Clarke N, Thornton P, Reader V, Lindsay N, Digby Z, Mullen B, Gorman M, Jacobson E, Langdon G, Johnstone H, Wheeler A, Watt AP (2025) Anti-Neuroinflammatory and Anti-Inflammatory Effects of the NLRP3 Inhibitor NT-0796 in Subjects with Parkinson\u2019s Disease. Mov Disord Off J Mov Disord Soc 40:2199\u20132208. https:\/\/doi.org\/10.1002\/mds.30307","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"12920_CR95","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fimmu.2019.00276","volume":"10","author":"Y Zhen","year":"2019","unstructured":"Zhen Y, Zhang H (2019) NLRP3 Inflammasome and Inflammatory Bowel Disease. Front Immunol 10:276. https:\/\/doi.org\/10.3389\/fimmu.2019.00276","journal-title":"Front Immunol"},{"key":"12920_CR96","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"JK Patra","year":"2018","unstructured":"Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S, Shin HS (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16:71. https:\/\/doi.org\/10.1186\/s12951-018-0392-8","journal-title":"J Nanobiotechnol"},{"key":"12920_CR97","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","volume":"20","author":"E Kon","year":"2023","unstructured":"Kon E, Ad-El N, Hazan-Halevy I, Stotsky-Oterin L, Peer D (2023) Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospects. Nat Rev Clin Oncol 20:739\u2013754. https:\/\/doi.org\/10.1038\/s41571-023-00811-9","journal-title":"Nat Rev Clin Oncol"},{"key":"12920_CR98","doi-asserted-by":"publisher","first-page":"e2305300","DOI":"10.1002\/adma.202305300","volume":"36","author":"Y Jia","year":"2024","unstructured":"Jia Y, Wang X, Li L, Li F, Zhang J, Liang XJ (2024) Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid. Adv Mater Deerfield Beach Fla 36:e2305300. https:\/\/doi.org\/10.1002\/adma.202305300","journal-title":"Adv Mater Deerfield Beach Fla"},{"key":"12920_CR99","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bioactmat.2021.11.027","volume":"14","author":"HS Han","year":"2022","unstructured":"Han HS, Koo SY, Choi KY (2022) Emerging nanoformulation strategies for phytocompounds and applications from drug delivery to phototherapy to imaging. Bioact Mater 14:182\u2013205. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.11.027","journal-title":"Bioact Mater"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12920-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12920-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12920-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:05:36Z","timestamp":1792541136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12920-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12920"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12920-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"15 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Statement The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declaration"}}],"article-number":"1766"}}